Q/C Technologies, Inc. Common Stock is a in vitro & in vivo diagnostic substances company trading on NASDAQ, led by CEO Joshua N. Silverman, with a market cap of $14.7M.
Upcoming earnings announcement for Q/C Technologies, Inc. Common Stock
Past 1 earnings report for Q/C Technologies, Inc. Common Stock
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 19, 2025 | Q3 2025 | -$2.50 | — | - | — |
We use cookies for analytics. See our Privacy and Cookie Policy.